Table 4.
Correlation analyses between the insulinogenic index and selected variables in diabetic and non-diabetic MetS patients.
| BMI | C-Peptide | HOMA-IR Index | |||
| Non-diabetic | Diabetic | Non-diabetic | Diabetic | Non-diabetic | Diabetic |
| +0.0853 (p = 0.68) |
+0.3856 (p < 0.01) |
−0.3426 (p = 0.09) |
+0.2859 (p < 0.01) |
−0.1173 (p < 0.57) |
+0.2699 (p < 0.01) |
| Glycated hemoglobin (HbA1C) | Total cholesterol | HDL cholesterol | |||
| Non-diabetic | Diabetic | Non-diabetic | Diabetic | Non-diabetic | Diabetic |
| +0.5669 (p < 0.01) |
+0.1765 (p = 0.12) |
+0.2139 (p = 0.30) |
+0.2250 (p < 0.05) |
+0.1897 (p = 0.36) |
+0.0866 (p = 0.46) |
| LDL cholesterol | Triglycerides | Leptin | |||
| Non-diabetic | Diabetic | Non-diabetic | Diabetic | Non-diabetic | Diabetic |
| +0.1786 (p = 0.39) |
+0.0626 (p = 0.59) |
+0.0127 (p = 0.95) |
+0.2155 (p < 0.05) |
+0.0666 (p = 0.83)a |
+0.3781 (p < 0.01)b |
| Adiponectin | Interleukin-6 | TNF-α | |||
| Non-diabetic | Diabetic | Non-diabetic | Diabetic | Non-diabetic | Diabetic |
| −0.141+ (p = 0.67)c |
−0.0563 (p = 0.69)d |
+0.2712 (p = 0.39)a |
+0.2747 (p < 0.05)d |
+0.5941 (p < 0.05)f |
+0.0426 (p = 0.76)e |
| hs-CRP | GLP-1 | ||||
| Non-diabetic | Diabetic | Non-diabetic | Diabetic | ||
| +0.3484 (p = 0.29)c |
+0.6560 (p < 0.01)g |
+0.2304 (p = 0.42)f |
−0.4838 (p < 0.01)h |
||
an = 12, b n = 54, c n =11, d n = 51, e n = 52, f n =14, g n = 39 and h n = 48. n =25 non-diabetic and 75 diabetic patients affected by MetS in all other cases.